Porton Pharma Solutions Ltd Sustainability Reports
Porton Pharma Solutions Ltd. operates as a pharmaceutical contract development and manufacturing organization (CDMO). The company provides custom development and manufacturing services for small molecules, TIDES, and antibody-drug conjugates from preclinical stages to commercial supply.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
LEI: 300300IQTJFHA0YRXE68
FIGI: BBG001TR5S27
5 reports from 2022 to 2025
